NCT07017972

Brief Summary

This protocol supports the reliable development and improvement of Artificial Intelligence (AI)-based applications by enabling training, verification, and validation using high-quality real clinical data. It also aims to enhance machine learning in developmental-use AI software. In addition, the professional user simulated use will ensure correct and easy use of the AI applications.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,000

participants targeted

Target at P75+ for all trials

Timeline
13mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Jun 2025Jun 2027

First Submitted

Initial submission to the registry

June 4, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 12, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

June 20, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2027

Last Updated

August 7, 2025

Status Verified

August 1, 2025

Enrollment Period

2 years

First QC Date

June 4, 2025

Last Update Submit

August 4, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Area under the curve (AUC) will be quantified using logistic regression to assess EQ Score's prediction of utilization.

    7 days

Interventions

AI evaluation of embryos inside a time-lapse incubator.

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

women undergoing In vitro fertilization (IVF) treatment

You may qualify if:

  • Images and data of eggs or embryos available from egg retrievals by women undergoing standard egg-freezing or In vitro fertilization (IVF) treatments, using their own eggs or donor eggs.
  • Women at least 18 years of age.
  • Embryos or eggs cultured in a time-lapse incubator connected to the AI Embryo Viewer.

You may not qualify if:

  • Women with no available own or donor eggs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New England Fertility Institute

Stamford, Connecticut, 06905, United States

RECRUITING

Study Officials

  • Klaus Wiemer, PhD

    Fairtility

    STUDY CHAIR

Central Study Contacts

Pedro Pini, M.D

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2025

First Posted

June 12, 2025

Study Start

June 20, 2025

Primary Completion (Estimated)

June 20, 2027

Study Completion (Estimated)

June 20, 2027

Last Updated

August 7, 2025

Record last verified: 2025-08

Locations